Curesign

Private

Tel AvivHealthcare & Life Scienceshttps://curesign.com/

Last Round

Seed

Feb 1, 2020

Company Overview

Curesign is a therapeutic devices company that develops medical devices designed to optimize oncology treatments.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Precision Medicine, Medical AI, Clinical Trials, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

precision oncologycancer treatment planningtreatment response monitoringmedical AImedical deviceadaptive treatmentelastographystiffness mappingclinical decision supportbiomarkerstumor segmentationsignal processingpreclinical studies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Curesign Comps

Public and private peers based on sector, stage, and business model.

Curesign comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Curesign Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Feb 1, 2020

View all Funding Rounds

Curesign Investors

Notable investors and investment history

Curesign investors
Investor	Rounds
Peregrine Ventures	Seed
Nacre Capital	Seed

View all Investors

Curesign Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Curesign Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Curesign's valuation, stock price, and market status.

Firmographic Details

HeadquartersTel Aviv

Employee Range1

Year Founded2019

Last FundingFeb 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.